---
title: "Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 ... — FDA record D-0623-2025 | Is It on Recall"
description: "Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity."
url: https://isitonrecall.com/recall/fda-drug-d-0623-2025-succinylcholine-chloride-injection-usp-200-mg-10-ml-20-mg-ml-rx-only-10-ml-multiple-dose-vial-steril/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufact... — FDA record D-0623-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 27, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton).
- **Reason**: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
- **Classification**: Class II
- **Recalling firm**: Zydus Pharmaceuticals (USA) Inc
- **Quantity**: 270,125 Vials
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0623-2025

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0623-2025%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #s: L400077, exp: 8/31/2025; L400113, exp.: 9/30/2025; L400372, L400373, exp.: 3/31/2026; L400374, exp.: 4/30/2026. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

MS, OH, LA, and Puerto Rico

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Louisiana](https://isitonrecall.com/state/louisiana/)
- [Mississippi](https://isitonrecall.com/state/mississippi/)
- [Ohio](https://isitonrecall.com/state/ohio/)

## Dates in the source

- **Report date**: Sep 17, 2025
- **Recall initiation date**: Aug 27, 2025
- **Center classification date**: Sep 8, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0623-2025%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Zydus Pharmaceuticals (USA) Inc records](https://isitonrecall.com/brand/zydus-pharmaceuticals-usa-inc/)